跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CUROSURF poractant alfa 120mg/1.5mL intratracheal suspension vial - TGA Drug Approval Details
Approvals
/
TGA
/
CUROSURF poractant alfa 120mg/1.5mL intratracheal suspension vial
Approved
STANDARD
CUROSURF poractant alfa 120mg/1.5mL intratracheal suspension vial
Chiesi Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
04c4512b910999dc
Company
Chiesi Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
04c4512b910999dc
Product Name
CUROSURF poractant alfa 120mg/1.5mL intratracheal suspension vial
Artg Id
99514
Artg Name
CUROSURF poractant alfa 120mg/1.5mL intratracheal suspension vial
Sponsor
Chiesi Australia Pty Ltd
Company Detail Path
/organization/chiesi-australia-pty-ltd
Artg Date
2005-02-28
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/4d62ddb6d18a97374f9c5660846a504f.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/4f4c5fec4658fc5252c633a0f4d7d546.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
04c4512b910999dc
Type
Standard
Back to TGA Approvals